QA: Globestar Therapeutics Corp in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001502152_2020_Globestar_Therapeutics_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001502152, Globestar Therapeutics Corp

  xvar xval
0 AssetsCurrent 141,361
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 822
3 remainder_Assets 0
4 LiabilitiesCurrent 827,618
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 163
8 SellingGeneralAndAdministrativeExpense 318,426
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 268,395
11 remainder_Revenues 1,035
12 remainder_NetIncome -193,828
13 remainder_ComprehensiveNetIncome -2,141
  yvar yval
0 Assets 142,183
1 Liabilities 827,618
2 Expenses 586,984
3 Revenues 1,035
4 StockholdersEquity -685,435
5 NetIncome -779,777
6 ComprehensiveNetIncome -780,848
7 BaseVar 876,894
8 EconomicCapitalRatiobeforeLimitedLiability -4.69
9 EconomicCapitalRatio 0.242

Edgar->Model Mapping

Feature Distribution

Change over Time